Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPREDNISOLONE Cause Dermatomyositis? 51 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Dermatomyositis have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.1% of all adverse event reports for METHYLPREDNISOLONE.

51
Reports of Dermatomyositis with METHYLPREDNISOLONE
0.1%
of all METHYLPREDNISOLONE reports
16
Deaths
30
Hospitalizations

How Dangerous Is Dermatomyositis From METHYLPREDNISOLONE?

Of the 51 reports, 16 (31.4%) resulted in death, 30 (58.8%) required hospitalization, and 4 (7.8%) were considered life-threatening.

Is Dermatomyositis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 51 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLPREDNISOLONE Cause?

Off label use (10,364) Drug ineffective (9,959) Product use in unapproved indication (4,115) Condition aggravated (3,784) Headache (3,419) Fatigue (3,250) Pyrexia (3,226) Pain (3,165) Nausea (3,105) Pneumonia (3,006)

What Other Drugs Cause Dermatomyositis?

METHOTREXATE (183) PREDNISONE (168) RITUXIMAB (152) HYDROXYCHLOROQUINE (146) ATORVASTATIN (133) MYCOPHENOLATE MOFETIL (110) NIVOLUMAB (84) ADALIMUMAB (82) HUMAN IMMUNOGLOBULIN G (69) TOFACITINIB (66)

Which METHYLPREDNISOLONE Alternatives Have Lower Dermatomyositis Risk?

METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPREDNISOLONE vs METILDIGOXIN METHYLPREDNISOLONE vs METOCLOPRAMIDE METHYLPREDNISOLONE vs METOLAZONE

Related Pages

METHYLPREDNISOLONE Full Profile All Dermatomyositis Reports All Drugs Causing Dermatomyositis METHYLPREDNISOLONE Demographics